Abstract:Introduction Among various lupus renal vascular changes, thrombotic microangiopathy (TMA) presented with the most severe clinical manifestations and high mortality. The pathogenesis of TMA in systemic lupus erythematosus (SLE) was complicated. The aim of this study was to assess clinical manifestations, laboratory characteristics, pathological features and risk factors for clinical outcomes of lupus nephritis patients co-existing with renal TMA in a large cohort in China. Methods Clinical and renal histopathological data of 148 patients with biopsy-proven lupus nephritis were retrospectively analyzed. Serum complement factor H, A Disintegrin and Metalloprotease with Thrombospondin type I repeats 13 (ADAMTS-13) activity, antiphospholipid antibodies and C4d deposition on renal vessels were further detected and analyzed. Results In the 148 patients with lupus nephritis, 36 patients were diagnosed as co-existing with renal TMA based on pathological diagnosis. Among the 36 TMA patients, their clinical diagnoses of renal TMA were as followings: 2 patients combining with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 2 patients combining with anti-phospholipid syndrome, 2 patients with malignant hypertension, 1 patient with scleroderma and the other 29 patients presenting with isolated renal TMA. Compared with the non-renal TMA group, patients with renal TMA had significantly higher urine protein (7.09 ± 4.64 vs. 4.75 ± 3.13 g/24h, P = 0.007) and serum creatinine (159, 86 to 215 vs. 81, 68 to 112 μmol/l, P <0.001), higher scores of total activity indices (AI) ( P <0.001), endocapillary hypercellularity ( P <0.001), subendothelial hyaline deposits ( P = 0.003), interstitial inflammation ( P = 0.005), glomerular leukocyte infiltration ( P = 0.006), total chronicity indices (CI) ( P = 0.033), tubular atrophy ( P = 0.004) and interstitial fibrosis ( P = 0.018). Patients with renal TMA presented with poorer renal outcome ( P = 0.005) compared with the non-TMA group. Renal TMA (hazard ratio (HR): 2.772, 95% confidence interval: 1.009 to 7.617, P = 0.048) was an independent risk factor for renal outcome in patients with lupus nephritis. The renal outcome was poorer for those with both C4d deposition and decreased serum complement factor H in the TMA group ( P = 0.007). Conclusions There were various causes of renal TMA in lupus nephritis. Complement over-activation via both classical and alternative pathways might play an important role in the pathogenesis of renal TMA in lupus nephritis.

Clinicopathologic Characteristics and Outcomes in Patients with Class Ⅳ Lupus Nephritis Presented with Thrombotic Microangiopathy

Clinical Characteristics and Prognosis of Diffuse Proliferative Lupus Nephritis with Thrombotic Microangiopathy.

Clinico-pathological Characteristics and Outcome of Patients with Thrombotic Microangiopathy

Risk and Prognostic Factors of Transplantation‐associated Thrombotic Microangiopathy in Allogeneic Haematopoietic Stem Cell Transplantation: a Nested Case Control Study

Clinicopathological Features and Outcomes of SLE Patients with Renal Injury Characterised by Thrombotic Microangiopathy.

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Clinicopathologic Characteristics and Outcomes of Renal Thrombotic Microangiopathy in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis

The Spectrum of Renal Thrombotic Microangiopathy in Lupus Nephritis

Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China

Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus

[Lupus nephritis and thrombotic microangiopathy: A review]

Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation

Clinical-pathological features and prognosis of thrombotic tbrombocytopenic purpura in patients with lupus nephritis

Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Clinical-pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients with Lupus Nephritis.

Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.

Clinical profile and outcomes of De novo posttransplant thrombotic microangiopathy

Thrombotic Microangiopathy with Concomitant GI Agvhd after Allogeneic Hematopoietic Stem Cell Transplantation: Risk Factors and Outcome

Long-term Outcome of Chinese Patients with Membranous Lupus Nephropathy